Overview

Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)

Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that post-exposure prophylaxis with hydroxychloroquine will reduce the symptomatic secondary attack rate among household contacts of known or suspected COVID-19 patients.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Columbia University
Treatments:
Hydroxychloroquine